Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A papillary carcinoma arising from the thyroid gland from multiple foci.
Biomarker and diagnostic research for multicentric papillary thyroid carcinoma has been reported in the published literature.
No clinical trials have been registered for multicentric papillary thyroid carcinoma.
21 publications have been identified in PubMed for multicentric papillary thyroid carcinoma. Research spans Epidemiology / Natural History (33%), Case Report / Case Series (19%), and Diagnostic / Biomarker (14%).
Research Type | Count | % of Total |
|---|---|---|
Disease patterns and progression | 7 | 33% |
Data assembled from 2 of 12 sources · Last updated Sep 19, 2026, 10:42 PM UTC
Patient case studies
4 |
19% |
Testing and diagnosis research | 3 | 14% |
Laboratory research | 3 | 14% |
Research summaries | 2 | 10% |
Other research | 1 | 5% |
Clinical study results | 1 | 5% |
Ghasoub R (2026). [PMID: 41883811](https://pubmed.ncbi.nlm.nih.gov/41883811/). *Case Rep Oncol*. [Case Report / Case Series]
McGarry JL (2026). [PMID: 42014296](https://pubmed.ncbi.nlm.nih.gov/42014296/). *Surgeon*. [Clinical Trial Publication]
Lai ML (2026). [PMID: 41251741](https://pubmed.ncbi.nlm.nih.gov/41251741/). *Virchows Arch*. [Epidemiology / Natural History]
Liu W (2026). [PMID: 41237514](https://pubmed.ncbi.nlm.nih.gov/41237514/). *Int J Med Inform*. [Epidemiology / Natural History]
Cavalheiro BG (2026). [PMID: 41819745](https://pubmed.ncbi.nlm.nih.gov/41819745/). *Braz J Otorhinolaryngol*. [Diagnostic / Biomarker]
Xing M (2025). [PMID: 41038186](https://pubmed.ncbi.nlm.nih.gov/41038186/). *Lancet Oncol*. [Epidemiology / Natural History]
Xiao W (2025). [PMID: 39881038](https://pubmed.ncbi.nlm.nih.gov/39881038/). *Eur Radiol*. [Diagnostic / Biomarker]
Güden İ (2025). [PMID: 40674296](https://pubmed.ncbi.nlm.nih.gov/40674296/). *Endocr Connect*. [Epidemiology / Natural History]
Kibar A (2025). [PMID: 40747807](https://pubmed.ncbi.nlm.nih.gov/40747807/). *Mol Imaging Radionucl Ther*. [Basic Science / Preclinical]
Xie R (2025). [PMID: 41094409](https://pubmed.ncbi.nlm.nih.gov/41094409/). *BMC Cancer*. [Epidemiology / Natural History]
AI-curated news mentioning multicentric papillary thyroid carcinoma
Updated Aug 29, 2026
A new study highlights the diffuse sclerosing variant of papillary thyroid carcinoma as a rare and invasive cancer in childhood. This research underscores the challenges in diagnosing and treating this specific cancer variant.
Recent research highlights the impact of TERT promoter variants and older age on the prognosis of papillary thyroid carcinoma. This study provides insights that could influence future treatment strategies and patient management.
A recent study indicates that incidentally detected papillary thyroid carcinoma does not negatively affect pregnancy outcomes during fertility treatment. This finding may influence clinical practices regarding the management of thyroid cancer in women seeking fertility assistance.